Rocket Doctor Expands to Florida, Empowering Independent MDs with AI

VANCOUVER, BC – November 02, 2026 – As corporate consolidation continues to reshape the American healthcare landscape, a counter-movement is quietly gaining momentum, fueled by artificial intelligence and a desire for physician autonomy. Rocket Doctor AI Inc. officially launched its digital health platform and marketplace in Florida today, marking the company’s expansion into its fourth U.S. state and setting the stage for a critical test of its physician-enablement model.

The expansion into the third-largest state in the country builds upon a foundation of approximately 24 million covered lives who currently have in-network access to the platform across California, New York, and Maryland. With an initial cohort of more than a dozen board-certified, Florida-licensed physicians already onboarded, the Vancouver-based health tech company is targeting one of the most demographically complex healthcare markets in the nation.

Florida represents a dynamic, high-stakes environment. The state is home to approximately 9 million Medicare and Medicaid beneficiaries, many of whom reside in care deserts spanning both sprawling urban centers and isolated rural counties. For Rocket Doctor, the Florida rollout is more than just geographic expansion; it is a strategic maneuver to prove that equipping independent doctors with enterprise-grade AI and billing infrastructure can effectively bridge the gap in Medicaid access while reversing the trend of physician burnout.

Tackling Florida's Care Deserts

The promise of digital health has long been its potential to democratize access to care, yet vulnerable populations—particularly those on Medicaid—frequently remain underserved by premier telehealth platforms. Rocket Doctor’s stated mission is to directly address this disparity.

"We are thrilled to officially expand Rocket Doctor into Florida as we continue scaling our footprint across the United States," said Dr. William Cherniak, Founder and CEO of Rocket Doctor Inc., in a statement. "Florida represents an incredible opportunity to expand access to care for the millions of Medicare and Medicaid beneficiaries who need fast, convenient and high-quality primary and urgent care. Building on the foundation we have established across our existing payer partnerships Coast to Coast, we are eager to empower Florida physicians to be able to serve millions of patients across urban, rural, and underserved communities statewide."

Integrating into Florida's payer ecosystem is no small feat. The state’s Statewide Medicaid Managed Care (SMMC) program underwent a massive restructuring that took effect in early 2025, transitioning to nine regional contracts dominated by heavyweights like Humana, Sunshine State Health Plan, and Simply Healthcare. While Rocket Doctor has not publicly disclosed specific in-network agreements with these Florida-centric plans at launch, the company’s recent financial filings indicate a robust trajectory in securing payer contracts. In late 2025, the firm successfully navigated credentialing with six major insurance companies across Medicare Advantage and Medicaid Managed Care in other states.

Industry analysts note that securing direct in-network status with Florida's SMMC plans will be the ultimate litmus test for the platform's local viability. A phased approach to managed care plan integration is typical for platforms scaling state-by-state, but establishing those deep payer connections is essential to capturing the high-volume Medicaid demographic the company is targeting.

The Counter-Trend to Corporate Rollups

What distinguishes Rocket Doctor in a crowded digital health market is its fundamental business architecture. While established telehealth giants like Teladoc Health, Amwell, and Evernorth’s MDLive largely employ physicians directly or operate as white-label infrastructure for massive health systems, Rocket Doctor operates as a physician-enablement platform.

This model serves as a direct antidote to the relentless wave of corporate and hospital acquisitions swallowing independent medical practices. By providing proprietary digital health software, comprehensive billing infrastructure, and clinical workflow tools, the platform allows doctors to launch and manage their own independent virtual or hybrid care practices.

"The administrative burden of running a private practice has become insurmountable for many primary care providers, driving them into the arms of large hospital networks where they often lose clinical autonomy," noted a healthcare policy analyst familiar with the Florida market. "Platforms that offload the back-office friction and billing complexities allow physicians to remain independent while still participating in the modern, hybrid-care economy."

For the initial dozen Florida physicians utilizing the platform, the appeal lies in restoring professional autonomy. The technology handles the operational friction, theoretically creating more time for meaningful physician-patient interactions. To date, the company claims to have empowered over 350 medical doctors to provide care across more than 800,000 patient visits throughout North America.

Evaluating AI Integration and Clinical Validation

A cornerstone of the company’s pitch to both physicians and investors is its proprietary technology, specifically the Global Library of Medicine (GLM). Described as a clinically validated decision support system developed with input from hundreds of physicians worldwide, the GLM utilizes advanced artificial intelligence and large language models to assist doctors at the point of care.

In the rapidly evolving regulatory landscape of clinical decision support software (CDSS), the integration of AI requires careful navigation. The U.S. Food and Drug Administration maintains stringent guidelines differentiating software that provides actionable diagnostic recommendations from tools intended purely for informational review by a human expert. While specific FDA classifications for the GLM are not prominently detailed in public consumer filings, the company’s ongoing research—including a reported $2 million NIH grant advancing the GLM—signals a serious commitment to clinical validation and peer-reviewed backing.

For independent physicians, AI-driven decision support is increasingly viewed not as a replacement for clinical judgment, but as a necessary tool to manage the complex, compounding chronic conditions often prevalent in Medicare and Medicaid populations. By reducing cognitive load and ensuring greater consistency in care pathways, the GLM aims to make independent practice not just administratively feasible, but clinically superior.

The Micro-Cap Playbook and the Road Ahead

From a market perspective, Rocket Doctor AI Inc. is executing an aggressive state-by-state playbook. As a micro-cap company trading on the Canadian Securities Exchange and OTC markets, demonstrating scalable, capital-efficient growth is paramount. The financial indicators suggest the model is gaining traction; the company reported a 43% year-over-year increase in revenue for the second quarter of 2026, largely driven by its expanding U.S. in-network payer agreements. Furthermore, U.S. patient visits nearly tripled in that same timeframe.

However, scaling a physician marketplace requires localized, grassroots engagement. To that end, the company is deploying unconventional marketing strategies to build brand awareness in its new territory. Team members will be on-site in Miami on November 8, supporting the No. 51 car at the NASCAR Straight Talk Wireless 400 at Homestead-Miami Speedway. This direct-to-consumer and direct-to-physician outreach highlights the dual-sided nature of their marketplace: they must simultaneously attract patients seeking care and doctors willing to provide it.

Florida’s generally supportive regulatory environment for telehealth, including payment parity provisions for certain services, provides a favorable tailwind for this expansion. Yet, the competitive landscape remains fierce. Rocket Doctor must prove that its unique blend of AI-powered clinical support, independent practice enablement, and a focus on underserved Medicaid populations can carve out a sustainable, profitable niche against entrenched corporate telehealth providers.

As the platform goes live across the Sunshine State, healthcare executives, policymakers, and investors will be watching closely. The success or failure of this expansion will offer critical signals about the viability of independent medical practice in the digital age, and whether AI can truly be leveraged to dismantle the care deserts that have long plagued America's most vulnerable communities.